See also this year's filing and all EDGAR filings for this company.
PDF Report 0001338042_2014_Aegerion_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001338042, Aegerion Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 140,514,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,654,000 |
| 3 | remainder_Assets | 164,000 |
| 4 | LiabilitiesCurrent | 24,844,000 |
| 5 | LiabilitiesNoncurrent | 4,011,000 |
| 6 | remainder_Liabilities | 445,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 76,082,000 |
| 9 | ResearchAndDevelopmentExpense | 29,788,000 |
| 10 | remainder_Expenses | 6,092,000 |
| 11 | remainder_Revenues | 48,546,000 |
| 12 | remainder_NetIncome | 58,000 |
| 13 | remainder_ComprehensiveNetIncome | 11,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 142,332,000 |
| 1 | Liabilities | 29,300,000 |
| 2 | Expenses | 111,962,000 |
| 3 | Revenues | 48,546,000 |
| 4 | StockholdersEquity | 113,032,000 |
| 5 | NetIncome | -63,358,000 |
| 6 | ComprehensiveNetIncome | -63,352,500 |
| 7 | BaseVar | 166,104,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.13 |
| 9 | EconomicCapitalRatio | 3.11 |
Edgar->Model Mapping
Feature Distribution
Change over Time
